These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20890765)

  • 21. Diverse effects of LPA4, LPA5 and LPA6 on the activation of tumor progression in pancreatic cancer cells.
    Ishii S; Hirane M; Fukushima K; Tomimatsu A; Fukushima N; Tsujiuchi T
    Biochem Biophys Res Commun; 2015 May; 461(1):59-64. PubMed ID: 25849892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential function of lysophosphatidic acid receptors in cell proliferation and migration of neuroblastoma cells.
    Hayashi M; Okabe K; Kato K; Okumura M; Fukui R; Fukushima N; Tsujiuchi T
    Cancer Lett; 2012 Mar; 316(1):91-6. PubMed ID: 22079467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequent mutations of lysophosphatidic acid receptor-1 gene in rat liver tumors.
    Obo Y; Yamada T; Furukawa M; Hotta M; Honoki K; Fukushima N; Tsujiuchi T
    Mutat Res; 2009 Jan; 660(1-2):47-50. PubMed ID: 19000703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lysophosphatidic acid signaling via LPA
    Fukushima K; Takahashi K; Yamasaki E; Onishi Y; Fukushima N; Honoki K; Tsujiuchi T
    Exp Cell Res; 2017 Mar; 352(1):139-145. PubMed ID: 28189636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of LPA4/p2y9/GPR23 in negative regulation of cell motility.
    Lee Z; Cheng CT; Zhang H; Subler MA; Wu J; Mukherjee A; Windle JJ; Chen CK; Fang X
    Mol Biol Cell; 2008 Dec; 19(12):5435-45. PubMed ID: 18843048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of lysophosphatidic acid receptor-3 enhances cell migration in rat lung tumor cells.
    Hayashi M; Okabe K; Yamawaki Y; Teranishi M; Honoki K; Mori T; Fukushima N; Tsujiuchi T
    Biochem Biophys Res Commun; 2011 Feb; 405(3):450-4. PubMed ID: 21255556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparing the differential effects of LPA on the barrier function of human pulmonary endothelial cells.
    Ren Y; Guo L; Tang X; Apparsundaram S; Kitson C; Deguzman J; Fuentes ME; Coyle L; Majmudar R; Allard J; Truitt T; Hamid R; Chen Y; Qian Y; Budd DC
    Microvasc Res; 2013 Jan; 85():59-67. PubMed ID: 23084965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting lysophosphatidic acid receptor type 1 with Debio 0719 inhibits spontaneous metastasis dissemination of breast cancer cells independently of cell proliferation and angiogenesis.
    David M; Ribeiro J; Descotes F; Serre CM; Barbier M; Murone M; Clézardin P; Peyruchaud O
    Int J Oncol; 2012 Apr; 40(4):1133-41. PubMed ID: 22200658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lysophosphatidic acid receptor 4 signaling potentially modulates malignant behavior in human head and neck squamous cell carcinoma cells.
    Matayoshi S; Chiba S; Lin Y; Arakaki K; Matsumoto H; Nakanishi T; Suzuki M; Kato S
    Int J Oncol; 2013 May; 42(5):1560-8. PubMed ID: 23467751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autotaxin and LPA1 and LPA5 receptors exert disparate functions in tumor cells versus the host tissue microenvironment in melanoma invasion and metastasis.
    Lee SC; Fujiwara Y; Liu J; Yue J; Shimizu Y; Norman DD; Wang Y; Tsukahara R; Szabo E; Patil R; Banerjee S; Miller DD; Balazs L; Ghosh MC; Waters CM; Oravecz T; Tigyi GJ
    Mol Cancer Res; 2015 Jan; 13(1):174-85. PubMed ID: 25158955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different expressions and DNA methylation patterns of lysophosphatidic acid receptor genes in mouse tumor cells.
    Okabe K; Hayashi M; Wakabayashi N; Yamawaki Y; Teranishi M; Fukushima N; Tsujiuchi T
    Pathobiology; 2010; 77(6):309-14. PubMed ID: 21266829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LPA
    Dancs PT; Ruisanchez É; Balogh A; Panta CR; Miklós Z; Nüsing RM; Aoki J; Chun J; Offermanns S; Tigyi G; Benyó Z
    FASEB J; 2017 Apr; 31(4):1547-1555. PubMed ID: 28069828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual mode regulation of migration by lysophosphatidic acid in human gastric cancer cells.
    Shida D; Kitayama J; Yamaguchi H; Hama K; Aoki J; Arai H; Yamashita H; Mori K; Sako A; Konishi T; Watanabe T; Sakai T; Suzuki R; Ohta H; Takuwa Y; Nagawa H
    Exp Cell Res; 2004 Dec; 301(2):168-78. PubMed ID: 15530853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LPA
    Suckau O; Gross I; Schrötter S; Yang F; Luo J; Wree A; Chun J; Baska D; Baumgart J; Kano K; Aoki J; Bräuer AU
    Dev Dyn; 2019 May; 248(5):375-395. PubMed ID: 30847983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cross-talk between LPA1 and epidermal growth factor receptors mediates up-regulation of sphingosine kinase 1 to promote gastric cancer cell motility and invasion.
    Shida D; Fang X; Kordula T; Takabe K; Lépine S; Alvarez SE; Milstien S; Spiegel S
    Cancer Res; 2008 Aug; 68(16):6569-77. PubMed ID: 18701480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lysophosphatidylethanolamine utilizes LPA(1) and CD97 in MDA-MB-231 breast cancer cells.
    Park SJ; Lee KP; Kang S; Chung HY; Bae YS; Okajima F; Im DS
    Cell Signal; 2013 Nov; 25(11):2147-54. PubMed ID: 23838008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LPA-induced migration of ovarian cancer cells requires activation of ERM proteins via LPA
    Park J; Jang JH; Oh S; Kim M; Shin C; Jeong M; Heo K; Park JB; Kim SR; Oh YS
    Cell Signal; 2018 Apr; 44():138-147. PubMed ID: 29329782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Roles of endothelial cells in the regulation of cell motility via lysophosphatidic acid receptor-2 (LPA
    Minami K; Ueda N; Ishimoto K; Kurisu R; Takamoto M; Ikeda H; Tsujiuchi T
    Exp Mol Pathol; 2021 Feb; 118():104596. PubMed ID: 33347862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors.
    Ohta H; Sato K; Murata N; Damirin A; Malchinkhuu E; Kon J; Kimura T; Tobo M; Yamazaki Y; Watanabe T; Yagi M; Sato M; Suzuki R; Murooka H; Sakai T; Nishitoba T; Im DS; Nochi H; Tamoto K; Tomura H; Okajima F
    Mol Pharmacol; 2003 Oct; 64(4):994-1005. PubMed ID: 14500756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of LPA
    Takahashi K; Fukushima K; Otagaki S; Ishimoto K; Minami K; Fukushima N; Honoki K; Tsujiuchi T
    J Recept Signal Transduct Res; 2018 Feb; 38(1):71-75. PubMed ID: 29369010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.